Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Home
>
Premium Biotech Coverage
>
Current News
Current News
Categories
Categories
Actinogen (ACW)
Adalta (1AD)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Patrys (PAB)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
March 27th, 2025
Telix Gains Approval for First of Three Diagnostics for 2025
Read More
March 26th, 2025
Actinogen Medical: Progressing its Phase IIb/III Alzheimer's Study
Read More
March 26th, 2025
Syntara Accelerates Wound Healing Program
Read More
March 26th, 2025
Blinklab Initiates Lead-In to Pivotal Study for Autism Diagnostic Aid
Read More
March 6th, 2025
Chimeric Therapeutics Receives Sizeable Donation
Read More
March 5th, 2025
Telix Forecasts Minimum 50% Revenue Jump for 2025 to $1.2 billion
Read More
March 5th, 2025
Neuren Pharmaceuticals Continues to Build Cash Balance
Read More
March 5th, 2025
Clinuvel Pharmaceuticals Unveils 'Pavilion of Photomedicine' at AAD Meeting
Read More
March 3rd, 2025
Percheron Survives First Board Spill Attempt
Read More
March 3rd, 2025
Complete Response Rate of 57% in Imugene's Latest Azer-Cel Phase Ib Study
Read More
Pages
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
